Omada Health beats on revenue in first earnings report since IPO

Omada Health has announced its financial performance for the second quarter, marking its first earnings report since the initial public offering (IPO) in June. The virtual care provider revealed a remarkable 49% increase in revenue, rising to $41.21 million compared to the same quarter last year. Despite the revenue growth, the company reported a net loss of $5.31 million, translating to a loss of 24 cents per share. This is an improvement over the previous year, when Omada recorded a net loss of $10.69 million, or $1.40 per share. CEO Sean Duffy expressed optimism about the company’s performance, stating, "We believe our Q2 results highlight Omada's capacity to harness the momentum in cardiometabolic care, effectively promote our GLP-1 Care Track, and utilize advancements in artificial intelligence to benefit our members." Looking ahead, Omada projects full-year revenue between $235 million to $241 million, outperforming analyst expectations of $222 million. The company also anticipates an adjusted EBITDA loss ranging from $9 million to $5 million, which is better than the expected loss of $20.2 million reported by FactSet analysts. Founded in 2012, Omada Health provides virtual care services aimed at managing chronic conditions such as prediabetes, diabetes, and hypertension. The company employs a "between-visit care model" that complements traditional healthcare methods. After debuting on the Nasdaq with shares priced at $23, the stock closed at $19.46 on Thursday. Omada's member base reached 752,000 at the end of the second quarter, reflecting a 52% year-on-year increase. The results will be further discussed during the company's quarterly investor call scheduled for 4:30 p.m. ET.